Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-82,361
Closed -$6.23M 309
2026
Q1
$6.23M Hold
82,361
0.03% 192
2025
Q4
$6.14M Hold
82,361
0.03% 182
2025
Q3
$5.56M Sell
82,361
-36,769
-31% -$2.44M 0.03% 189
2025
Q2
$7.76M Buy
+119,130
New +$7.14M 0.04% 182
2023
Q3
Sell
-21,955
Closed -$1.78M 254
2023
Q2
$1.78M Hold
21,955
0.01% 209
2023
Q1
$1.77M Sell
21,955
-130,740
-86% -$10.5M 0.01% 175
2022
Q4
$11.5M Sell
152,695
-155,004
-50% -$11M 0.08% 139
2022
Q3
$19.9K Sell
307,699
-198,755
-39% -$13.8M 0.14% 103
2022
Q2
$35.1K Sell
506,454
-180,450
-26% -$13.4M 0.22% 89
2022
Q1
$52.8K Buy
686,904
+197,892
+40% +$14.2M 0.29% 59
2021
Q4
$34.4K Buy
489,012
+136,187
+39% +$10M 0.18% 86
2021
Q3
$26M Buy
352,825
+193,724
+122% +$14.5M 0.17% 91
2021
Q2
$10.6M Buy
+159,101
New +$10.6M 0.07% 134

Other funds holding HOLX

AustralianSuper's HOLX Position: Q2 2026 in Review

AustralianSuper sold out of Hologic (HOLX) in Q2 2026, closing a stake of 82,361 shares — an estimated $6.23M sold.

AustralianSuper first reported a position in HOLX in Q2 2021 and held it in 13 quarters. The position peaked at $26M in Q3 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • AustralianSuper reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • AustralianSuper sold 82,361 Hologic shares in Q2 2026, an estimated $6.23M.
  • AustralianSuper first reported a position in Hologic in Q2 2021 and held it in 13 quarters.
  • AustralianSuper's Hologic position peaked at $26M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on AustralianSuper's 13F filing for Q2 2026, filed 12 Aug 2026.